ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 635831 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 635831; 2) Community: the network communities that were significantly associated with the response to NSC 635831; 3) Molecule: the relationships between components within communities and NSC 635831; 4) MDR: the compounds that were significantly associated with the NSC 635831.

NSC Compound Enrichment Correlation
NSC 728040 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline 0.0385067071027343 0.41053222
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0385067071027343 0.26658087
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0385067071027343 0.14566684
NSC 747252 Trihexyl(tetradecyl)Phosphonium Hexafluorophosphate 0.0385067071027343 0.34615659
NSC 756833 Null 0.0385067071027343 -0.19535343
NSC 79304 Null 0.0385067071027343 0.43832966
NSC 99027 Null 0.0385067071027343 0.37395179
NSC 658995 Null 0.0386895225700407 0.10447834
NSC 686362 Null 0.0386895225700407 0.34154712
NSC 695588 6-Amino-3-chloromethyl-1-[(5-methoxyindole-2-yl)-sufonyl] indoline 0.0386895225700407 0.26591723
Total:108  Current:77    [First] [Prev] [Next] [Last]